Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2007-11-20
2007-11-20
Angell, Jon Eric (Department: 1635)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reexamination Certificate
active
10243124
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6627196 (2003-09-01), Baughman et al.
patent: 1067182 (2001-01-01), None
Antibodies (pages 321-323 and 342-352), Harlow and Lane, Editors (1989).
Pennica et al. Proceedings of the National Academy of the Sciences of the U.S.A. (1988) 95:14717-14722.
Konopka et al. Proceedings of the National Academy of the Sciences of the U.S.A. (1986) 83:4049-4052.
Haynes (Electrophoresis 1998; vol. 19(11), pp. 1862-1871).
Hancock (J. Proteome Research 2004; vol. 3(4), p. 585).
Hu (J. Proteome Res. 2003; vol. 2(4), pp. 405-412).
Wang (Trends Pharmacol. Sci. 1996; vol. 17(8):276-9).
Henikoff (Science 1997; p. 609, Abstract).
Saito-Hisaminato et al. (DNA Res., 9:35-45, 2002).
Czupalla et al (Proteomics (2005) 5:3868-3875).
Kwong et al (Genomics (2005) 26:142-158).
Chen et al (Mol. Cellular Proteomics (2002) 1:304-313).
Conrads et al (Mol. Cell Proteomics (2005) 4(9) :1284-1296).
Ginestier et al (Am. J. Pathol. (2002) 161:1223-1233).
Anderson et al (Electrophoresis (1997) 18:533-537).
Washburn et al (Proc. Natl. Acad. Sci. (2003) 100 (6):3107-3112).
Meric et al (Molecular Cancer Therapeutics (2002) 1:971-979.
Klein et al., “Selection for genes encoding secreted proteins and receptors”Proc. Nat. Acad. Sci. USA93:7108-7113 (1996).
Dayhoff, Accession No. P—ABG34066, WO200224888-A2, Pub date: Mar. 28, 2002, Baker, et al.
Dayhoff, Accession No. P—AAB47298, WO200140465-A2, Pub date: Jun. 7, 2002, Fong et al.
Dayhoff, Accession No. P—AAB88464, EP1067182-A2, Pub date: Jan. 10, 2001, Ota et al.
Dayhoff, CAC39828, EP1067182-A 295, Jan. 10, 2001, Ota, et al.
Dayhoff, BAC11697, Direct Submission, Submitted Mar. 20, 2002, Isogai et al.
Dayhoff, Accession No. P—AAU83229, WO200202621-A2, Pub date: Jan. 10, 2002, Sheppard, et al.
Dayhoff, CAD28377, WO0202621-A 309, Jan. 10, 2002, Sheppard, et al.
Genbank, Accession No. AX164143, WO140465-1 15, Jun. 7, 2001, Fong et al.
Genbank, Accession No. AX136373, EP 1067182-A, Jan. 10, 2001, Ota et al.
Genbank, Accession No. AK075558, Direct Submission, Submitted Mar. 20, 2002, Isogai et al.
Genbank Accession No. BD123639, JP 2002017376-A 148, Jan. 22, 2002, Ota et al.
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104-9 (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol.,—130(6):860-8 (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matirx Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713-24 (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787-98 (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409-12 (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dendritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods.—246(1-2):79-90 (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis.—2(6):518-28 (1997) Abstract.
Caberlotto, L. et al., “Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191-4 (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736-46 (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41-6 (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3):279-84 (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC Activity and Expression by TNF-Alpha in Alveolar Epithelial Cells,”Am J. Physio Lung Cell Mol Physiol.—286(2):L301-11 (2004) Abstract.
De Boer, C.J., et al., “Involement of the CCNDI Gene in Hairy Cell Leukemia,”Ann Oncol.—7(3):251-6 (1996) Abstract.
Debieve, F., et al., “Inhibin and Activin Production and Subunit Expression in Human Placental Cells Cultured in Vitro,”Mol Hum Reprod.—6(8):743-9 (2000) Abstract.
Dong, Z., et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected withP. aeruginosa,” Invest Opthalmol Vis Sci—42(13):3223- (2001) Abstract.
Duchrow, M., et al., “Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR),”Cancer Invest.—19(6):588-96 (2001) Abstract.
Dyer, J., et al., “Molecular Characterisation of Carbohydrate Digestion and Absorption in Equine Small Intestine,”Equine Vet J.—34(4):349-58 (2002) Abstract.
Egwuagu, C.E., et al., “Suppressors of Cytokine Signaling Proteins are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance,”J Immunol.—168(7):3181-7 (2002) Abstract.
El-Ghrably, I.A., et al., “Intravitreal Invading Cells Contribute to Vitreal Cytokin Milieu in Proliferative Vitreoretinopathy,”Br J Opthalmol.—85(4):461-70 (2001) Abstract.
Eleore, L., et al., “Modulation of the Glutamatergic Receptors (AMPA and NMDA) and of Glutamate Vesicular Transporter 2 in the Rat Facial Nucleus after Axotomy,”Neuroscience—136(1):147-60 (2005) Abstract.
Forsberg, H., et al., “Altered Levels of Scavenging Enzymes in Embryos Subjected to a Diabetic Environment,”Free Radic Res.—24(6):451-9 (1996) Abstract.
Freyschuss, B., et al., “Induction of the Estrogen Receptor by Growth Hormone and Glucocorticoid Substitution in Priminary Cultures of Rat Hepatocytes,”Endocrinology—133(4):1548-54 (1993) Abstract.
Fu, K., et al., “Cyclin D1-Negative Mantle Cell Lymphoma: A Clinocopathologic Study Based on Gene Expression Profiling,”Blood—106(13):4315-21 (2005) Abstract.
Fuchs, A.R., et al., “Oxytocin Receptors in Bovine Cervix: Distrubution and Gene Expression During the Estrous Cycle,”Biol Reprod.—54(3):700-8 (1996) Abstract.
Furuta, J., et al., “Silencing of the Thrombomodulin Gene in Human Malignant Melanoma,”Melanoma Res.—15(1):15-20 (2005) Abstract.
Futcher, B., et al., “A Sampling of the Yeast Proteome,”Mol Cell Biol.,—19(11):7357-68 (1999) Abstract.
George, J., et al., “Pre-translational Regulation of Cytochrome P450 Genes is Responsible for Disease-Specific Changes of Individual P450 Enzymes Among Patients with Cirrhosis,”Biochem Pharmacol.—49(7):873-81 (1995) Abstract.
Giroux, M., et al., “Cyclooxygenase-2 Expression in Macrophages: Modulation by Protein Kinase C-alpha,”J immunol.—165(7):3985-91 (2002) Abstract.
Gnatenko,
Goddard Audrey
Gurney Austin L.
Smith Victoria
Watanabe Colin K.
Wood William I.
Angell Jon Eric
Barnes Elizabeth M.
Dreger, Esq. Ginger R.
Genentech Inc.
Kresnak Mark T.
LandOfFree
Anti-PRO10268 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-PRO10268 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-PRO10268 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3821679